Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T61844 | HIV-1 inhibitor-9 | ||
HIV-1 inhibitor-9 exhibits potent inhibition activity at low nanomolar concentrations against both the wild-type (WT) HIV-1 strain and multiple strains that have developed resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs). | |||
T62156 |
HIV-1 integrase inhibitor 9
|
||
HIV-1 integrase inhibitor 9 (compound 8a) 是一种 HIV-1 RNase H 的有效抑制剂 (IC50: 12.3 μM),具有抗病毒作用。 | |||
T74211 | HIV-1 inhibitor-12 | ||
HIV-1inhibitor-12 是有效的 HIV-1抑制剂。HIV-1inhibitor-12 抑制 HIV-1衣壳蛋白聚合,IC50为 9 nM。 | |||
T79974 |
HIV-IN-8
|
||
HIV-IN-8(Compound 9)为抗HIV药物,通过抑制HIV复制发挥作用,其半抑制浓度(EC50)为13 μg/mL。 | |||
T61797 |
HIV-1 inhibitor-15
|
||
HIV-1 inhibitor-15 (compound 9d) is a potent and broad-spectrum inhibitor targeting HIV-1. It exhibits inhibitory activity against HIV-1 WT, L100I, K103N, Y181C, and E138K with respective EC50 values of 1.7 nM, 4 nM, 2 nM, 6 nM, and 9 nM. In addition to its high efficacy, HIV-1 inhibitor-15 possesses favorable solubility, safety profiles, and oral bioavailability [1]. | |||
T82194 |
HIV-IN-9
|
||
HIV-IN-9 (Compound 2b)为一种HIV抑制剂,IC50值为6.65 μg/mL,对HIV-RT展现出高度结合亲和力。此外,HIV-IN-9亦能抑制CYP3A4、CYP1A2、CYP2C1和CYP2D6等多种酶。 | |||
T79295 | HIV-1 protease-IN-9 | HIV Protease | Microbiology/Virology; Proteases/Proteasome |
HIV-1protease-IN-9 (compound 5b)为HIV-1蛋白酶抑制剂,具有0.028 nM的Ki值和66.8 nM的IC50,表现出显著的抗病毒活性。 | |||
T35762 | MC1742 | ||
MC1742 is an inhibitor of class I histone deacetylases (HDACs; IC50s = 0.1, 0.11, 0.02, and 0.61 μM for HDAC1, -2, -3, and -8, respectively) and class IIb HDACs (IC50s = 7 and 40 nM for HDAC6 and HDAC10, respectively).1 It is selective for class I and class IIb over class IIa HDACs (IC50s = >50 μM for HDAC4, -5, -7, and -9). MC1742 reduces proliferation of HOS, MG-63, RD, A204, SK-ES-1, and A673 sarcoma cancer stem cells (CSCs). It increases levels of acetylated histone H3 and acetylated tubulin... |